192 related articles for article (PubMed ID: 22752161)
1. Pseudomonas aeruginosa bacteriophage PA1Ø requires type IV pili for infection and shows broad bactericidal and biofilm removal activities.
Kim S; Rahman M; Seol SY; Yoon SS; Kim J
Appl Environ Microbiol; 2012 Sep; 78(17):6380-5. PubMed ID: 22752161
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models.
Tiwari BR; Kim S; Rahman M; Kim J
J Microbiol; 2011 Dec; 49(6):994-9. PubMed ID: 22203564
[TBL] [Abstract][Full Text] [Related]
3. Assessment of biofilm removal capacity of a broad host range bacteriophage JHP against Pseudomonas aeruginosa.
Shafique M; Alvi IA; Abbas Z; Ur Rehman S
APMIS; 2017 Jun; 125(6):579-584. PubMed ID: 28418081
[TBL] [Abstract][Full Text] [Related]
4. The adsorption of Pseudomonas aeruginosa bacteriophage phiKMV is dependent on expression regulation of type IV pili genes.
Chibeu A; Ceyssens PJ; Hertveldt K; Volckaert G; Cornelis P; Matthijs S; Lavigne R
FEMS Microbiol Lett; 2009 Jun; 296(2):210-8. PubMed ID: 19459952
[TBL] [Abstract][Full Text] [Related]
5. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
[TBL] [Abstract][Full Text] [Related]
6. Complete genome sequence of Pseudomonas aeruginosa lytic bacteriophage PA1O which resembles temperate bacteriophage D3112.
Kim S; Rahman M; Kim J
J Virol; 2012 Mar; 86(6):3400-1. PubMed ID: 22354942
[TBL] [Abstract][Full Text] [Related]
7. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
[TBL] [Abstract][Full Text] [Related]
8. Bacteriophages of Pseudomonas aeruginosa: long-term prospects for use in phage therapy.
Krylov VN
Adv Virus Res; 2014; 88():227-78. PubMed ID: 24373314
[TBL] [Abstract][Full Text] [Related]
9. P. aeruginosa flow-cell biofilms are enhanced by repeated phage treatments but can be eradicated by phage-ciprofloxacin combination.
Henriksen K; Rørbo N; Rybtke ML; Martinet MG; Tolker-Nielsen T; Høiby N; Middelboe M; Ciofu O
Pathog Dis; 2019 Mar; 77(2):. PubMed ID: 30821815
[TBL] [Abstract][Full Text] [Related]
10. Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms.
Pires D; Sillankorva S; Faustino A; Azeredo J
Res Microbiol; 2011 Oct; 162(8):798-806. PubMed ID: 21782936
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining?
Brüssow H
mBio; 2012; 3(2):. PubMed ID: 22493030
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.
Olszak T; Zarnowiec P; Kaca W; Danis-Wlodarczyk K; Augustyniak D; Drevinek P; de Soyza A; McClean S; Drulis-Kawa Z
Appl Microbiol Biotechnol; 2015 Jul; 99(14):6021-33. PubMed ID: 25758956
[TBL] [Abstract][Full Text] [Related]
13. Identification of a lytic Pseudomonas aeruginosa phage depolymerase and its anti-biofilm effect and bactericidal contribution to serum.
Mi L; Liu Y; Wang C; He T; Gao S; Xing S; Huang Y; Fan H; Zhang X; Yu W; Mi Z; Tong Y; Bai C; Han F
Virus Genes; 2019 Jun; 55(3):394-405. PubMed ID: 30937696
[TBL] [Abstract][Full Text] [Related]
14. Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections.
Pires DP; Vilas Boas D; Sillankorva S; Azeredo J
J Virol; 2015 Aug; 89(15):7449-56. PubMed ID: 25972556
[TBL] [Abstract][Full Text] [Related]
15. [Effects of bacteriophages on biofilm formation by strains of Pseudomonas aeruginosa].
Gabisoniya TG; Loladze MZ; Nadiradze MM; Chakhunashvili NK; Alibegashvili MG; Tamarashvili NG; Pushkina VA
Prikl Biokhim Mikrobiol; 2016; 52(3):312-7. PubMed ID: 29509387
[TBL] [Abstract][Full Text] [Related]
16. Bacteriophage ecology in Escherichia coli and Pseudomonas aeruginosa mixed-biofilm communities.
Kay MK; Erwin TC; McLean RJ; Aron GM
Appl Environ Microbiol; 2011 Feb; 77(3):821-9. PubMed ID: 21131510
[TBL] [Abstract][Full Text] [Related]
17. The novel Pseudomonas aeruginosa two-component regulator BfmR controls bacteriophage-mediated lysis and DNA release during biofilm development through PhdA.
Petrova OE; Schurr JR; Schurr MJ; Sauer K
Mol Microbiol; 2011 Aug; 81(3):767-83. PubMed ID: 21696457
[TBL] [Abstract][Full Text] [Related]
18. Phages of Pseudomonas aeruginosa: response to environmental factors and in vitro ability to inhibit bacterial growth and biofilm formation.
Knezevic P; Obreht D; Curcin S; Petrusic M; Aleksic V; Kostanjsek R; Petrovic O
J Appl Microbiol; 2011 Jul; 111(1):245-54. PubMed ID: 21554503
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of bacteriophage to control multidrug-resistant Pseudomonas aeruginosa planktonic cells and biofilm.
Adnan M; Ali Shah MR; Jamal M; Jalil F; Andleeb S; Nawaz MA; Pervez S; Hussain T; Shah I; Imran M; Kamil A
Biologicals; 2020 Jan; 63():89-96. PubMed ID: 31685418
[TBL] [Abstract][Full Text] [Related]
20. The biofilm life cycle and virulence of Pseudomonas aeruginosa are dependent on a filamentous prophage.
Rice SA; Tan CH; Mikkelsen PJ; Kung V; Woo J; Tay M; Hauser A; McDougald D; Webb JS; Kjelleberg S
ISME J; 2009 Mar; 3(3):271-82. PubMed ID: 19005496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
